Related Experiment Videos
Aerosols in bronchiolitis
1Department of Child Health, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, PO Box 65, Leicester LE2 7LX, United Kingdom. pwb1@le.ac.uk
Insights
Bronchiolitis, a common infant respiratory illness, causes significant morbidity and strains healthcare resources. Current supportive care lacks proven therapies to shorten hospital stays, necessitating further research into treatments.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Infectious Diseases
Background:
- Bronchiolitis is a frequent lower respiratory tract infection in infants.
- It leads to substantial short- and long-term health issues, including hospitalization and mortality.
- Infants with pre-existing conditions and the very young are most vulnerable.
Purpose of the Study:
- To review the clinical course of infant bronchiolitis.
- To discuss proposed aerosolized therapies for bronchiolitis treatment.
Main Methods:
- Literature review of clinical course.
- Discussion of proposed aerosolized treatment strategies.
Main Results:
- Bronchiolitis presents a significant healthcare burden due to its prevalence and seasonal nature.
- Supportive care is the primary treatment modality.
- No current therapies are proven to reduce hospitalization or intensive care duration.
Conclusions:
- Bronchiolitis requires significant healthcare resources.
- Effective therapeutic interventions are lacking.
- Further investigation into aerosolized therapies is warranted.
Abstract:
Bronchiolitis is a common illness of the lower respiratory tract affecting infants that has considerable short and long-term morbidity and occasional mortality. It is the commonest cause of hospitalization for respiratory infection in early childhood, and the seasonal nature of the illness places considerable strain on health care resources during the bronchiolitis season. The youngest infants and those with preexisting cardiorespiratory disease are particularly at risk of severe illness. The treatment of infants with bronchiolitis is largely supportive. There are no therapies that have been proven to reduce the length of the hospitalization or intensive care stay. This paper will review the clinical course of bronchiolitis and discuss the aerosolized therapies that have been proposed for its treatment.